BREAST CANCER: Symptoms, Diagnosis, Treatment, Stages, Facts

Breast Cancer: A Comprehensive Overview of Types, Causes, Diagnosis, Treatment, and Survival

Breast cancer is a malignant neoplasm that develops in the breast tissue, most commonly in the cells lining the milk ducts or the lobules that produce milk. It is the most frequently diagnosed cancer among women worldwide and a leading cause of cancer-related mortality. Breast cancer can also occur in men, though it is rare. The disease is characterized by the uncontrolled growth of abnormal cells that can invade surrounding tissues and spread to distant organs through the bloodstream or lymphatic system, a process known as metastasis. Advances in screening, diagnosis, and treatment have dramatically improved outcomes, with the overall 5-year relative survival rate reaching 92% in the United States. This article provides an in-depth, evidence-based overview of breast cancer, covering its classification, causes, prevention strategies, symptoms, diagnostic methods, treatment modalities, staging, metastatic process, survival statistics, and frequently asked questions.

🔬 What Is Breast Cancer? Definition and ICD-10 Classification

Breast cancer is a primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males. The International Classification of Diseases, Tenth Revision (ICD-10) assigns the code C50 to malignant neoplasm of the breast. This code encompasses several subcategories based on the specific location within the breast:

C50.0: Malignant neoplasm of the nipple and areola
C50.1: Malignant neoplasm of the central portion of the breast
C50.2: Malignant neoplasm of the upper-inner quadrant of the breast
C50.3: Malignant neoplasm of the lower-inner quadrant of the breast
C50.4: Malignant neoplasm of the upper-outer quadrant of the breast
C50.5: Malignant neoplasm of the lower-outer quadrant of the breast
C50.6: Malignant neoplasm of the axillary tail of the breast
C50.8: Malignant neoplasm of overlapping sites of the breast
C50.9: Malignant neoplasm of the breast, unspecified

The ICD-10 coding system is essential for cancer registries, epidemiological research, and clinical documentation. It allows healthcare providers to classify and track breast cancer cases systematically.

🧬 Types of Breast Cancer

Breast cancer is classified by the type of cell from which it originates and whether it has spread beyond its original location. The main categories include:

🔬 Ductal Carcinoma

Ductal carcinoma begins in the cells that line the milk ducts. It is the most common type of breast cancer.

Ductal carcinoma in situ (DCIS) : A non-invasive form in which abnormal cells are confined to the lining of the milk ducts and have not spread to surrounding breast tissue. DCIS is also called stage 0 breast cancer and is considered noninvasive.
Invasive ductal carcinoma (IDC) : The most common breast cancer diagnosis. It begins in the milk ducts and has spread beyond the ducts into the surrounding breast tissue. It accounts for approximately 70–80% of all breast cancers.

🧬 Lobular Carcinoma

Lobular carcinoma begins in the lobules, the glands that produce milk.

Lobular carcinoma in situ (LCIS) : A non-invasive condition in which abnormal cells are found in the lobules. LCIS is not breast cancer but increases the risk of developing invasive breast cancer later in life.
Invasive lobular carcinoma (ILC) : Cancer cells have spread beyond the lobules into surrounding breast tissue. It grows more slowly and is less common than IDC. Lobular carcinoma is more often found in both breasts than other types of breast cancer.

🔥 Inflammatory Breast Cancer

Inflammatory breast cancer is a rare and aggressive form of breast cancer in which cancer cells block lymph vessels in the skin of the breast. This causes the breast to become red, swollen, and warm, often with a dimpled appearance resembling an orange peel (peau d’orange). Inflammatory breast cancer accounts for about 1% of all breast cancers and has a high risk of recurrence.

🧪 Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a form of breast cancer in which the cancer cells lack estrogen receptors, progesterone receptors, and HER2 protein. This form accounts for approximately 15–20% of all breast cancers and is more commonly diagnosed in younger patients. TNBC is associated with a higher risk of recurrence and a relatively poor prognosis compared to other subtypes.

🛡️ Other Rare Types

Paget disease of the breast: A rare type of cancer involving the skin of the nipple and areola. The first symptom is often a crusty or scaly nipple sore or discharge.
Phyllodes tumor: A rare type of breast tumor that starts in the connective tissue of the breast. Most phyllodes tumors are not cancer.
Metastatic breast cancer: Breast cancer that has spread from the breast to another part of the body. It is also called stage 4 breast cancer.

⚠️ What Causes Breast Cancer? Risk Factors and Etiology

The exact cause of breast cancer is not fully understood, but research has identified several key risk factors. Certain gene changes (mutations) in normal cells can affect the way genes work, causing abnormal cells to grow and lead to cancer. We don’t know exactly what causes each case of breast cancer, but there are some known risk factors.

🧬 Genetic and Hereditary Factors

About 5–10% of breast cancers are linked to inherited gene changes. Inherited gene changes are passed on in families and are present in cells throughout the body. The most common inherited cause of breast cancer is mutations in the BRCA1 and BRCA2 genes. About 1 in 2 women with changes in these genes will develop breast cancer, compared with 1 in 8 for women without BRCA gene changes. Other high-risk genes include CDH1, PALB2, PTEN, STK11, and TP53. Moderate-risk genes include ATM and CHEK2.

👩 Age and Gender

Age is a significant risk factor for breast cancer. The risk increases with age, with most cases diagnosed in women over 50. Being female is the single greatest risk factor; breast cancer is about 100 times more common in women than in men.

🏃 Lifestyle and Environmental Factors

Several lifestyle factors can influence breast cancer risk:

Alcohol consumption: Drinking alcohol is linked to an increased risk of breast cancer.
Obesity: Being overweight or obese, especially after menopause, increases risk.
Physical inactivity: A sedentary lifestyle is associated with higher risk.
Hormone replacement therapy (HRT) : Long-term use of combined estrogen and progestin HRT increases risk.
Reproductive history: Early menarche (before age 12), late menopause (after age 55), having no children, or having children after age 30 are associated with increased risk.
Radiation exposure: Exposure to ionizing radiation, especially during adolescence, increases risk.

🔥 Other Risk Factors

Dense breast tissue: Women with dense breast tissue have a higher risk of breast cancer.
Personal history of breast cancer: Women who have had breast cancer in one breast have an increased risk of developing cancer in the other breast.
Certain benign breast conditions: Some benign breast conditions, such as atypical hyperplasia, are associated with increased risk.

🛡️ How to Avoid and Prevent Breast Cancer

There is no sure way to prevent breast cancer, but certain lifestyle modifications and medical interventions may help lower risk.

🥗 Lifestyle Modifications

Maintain a healthy weight: Obesity is a risk factor for breast cancer, particularly after menopause. Losing excess weight through a balanced diet and regular exercise is recommended.

Limit alcohol consumption: The American Cancer Society recommends that women who drink alcohol limit themselves to no more than one alcoholic drink per day.

Stay physically active: Regular physical activity, aiming for at least 150 minutes of moderate-intensity exercise per week, is associated with reduced breast cancer risk.

Eat a balanced diet: A diet rich in fruits, vegetables, whole grains, and lean proteins, and low in saturated fats and processed foods, may help reduce risk.

💊 Chemoprevention

For women at high risk, medications such as tamoxifen or raloxifene may be prescribed to reduce the risk of developing breast cancer. These drugs block the effects of estrogen on breast tissue.

🔪 Risk-Reducing Surgery

Women with a very high risk of breast cancer, such as those with BRCA1 or BRCA2 mutations, may consider prophylactic mastectomy (surgical removal of the breasts) to reduce risk. This is a highly personal decision that should be made in consultation with healthcare providers.

🔍 Screening and Early Detection

Screening aims to detect breast cancer at an early stage, before symptoms appear, when treatment is most effective. The American Cancer Society (ACS) recommends the following screening guidelines for women at average risk:

Ages 40–44: Women should have the option to start annual screening with mammograms.
Ages 45–54: Women should get annual mammograms.
Ages 55 and older: Women can switch to mammograms every two years or continue yearly screening.

Women at high risk, such as those with BRCA mutations or a strong family history, may need to start screening earlier and may benefit from additional imaging, such as breast MRI.

🚨 Symptoms and Early Warning Signs

Breast cancer may not cause any signs or symptoms in its early stages. When symptoms do occur, they can vary widely.

🎗️ Common Symptoms

A new lump or mass in the breast: This is the most common symptom. A potentially cancerous lump is often firm, distinctive, and appears in one breast but not the other. It may feel distinctly different from the surrounding breast tissue.
Swelling in or near the breast or underarm: This may include swollen lymph nodes.
Change in the size or shape of the breast
Nipple discharge: Particularly if it is bloody or only in one breast.
Nipple inversion: The nipple turns inward.
Skin changes: Dimpling, puckering, or redness of the breast skin, sometimes resembling the skin of an orange (peau d’orange).

🔥 Symptoms of Inflammatory Breast Cancer

Inflammatory breast cancer presents differently. The breast becomes warm, red, and swollen, as if infected. The skin may become dimpled and leathery, and the nipple may turn inward. Often, no lump can be felt, but the entire breast is enlarged.

⚠️ Symptoms of Metastatic Disease

When breast cancer has spread to other organs, symptoms may include bone pain, weight loss, shortness of breath, cough, or headache, depending on the site of metastasis.

🔍 When to Seek Medical Attention

Any persistent breast change should be evaluated by a healthcare professional. While most breast lumps are not cancer, only a doctor can determine the cause.

🩺 Diagnosis: Mammogram, Ultrasound, MRI, and Biopsy

Diagnosing breast cancer involves a combination of clinical examination, imaging studies, and tissue analysis. The “triple test” approach is often used, which includes clinical breast examination, imaging, and biopsy if necessary.

🖥️ Imaging Techniques

Mammography: A mammogram is an X-ray of the breast and is the most common screening tool for breast cancer. It can detect tumors before they can be felt. About 85–90% of abnormalities detected during screening are not cancer, but mammography is designed to be sensitive enough to detect cancer at an early stage, sometimes years before it can be felt.

Ultrasound: Breast ultrasound uses high-frequency sound waves to create images of the breast. It is often used to evaluate abnormalities found on mammography and to guide biopsies. It is particularly useful for women with dense breast tissue.

Magnetic Resonance Imaging (MRI) : Breast MRI uses a powerful magnet, radio waves, and a computer to take detailed pictures of areas inside the breast. It is often used for screening in women at high risk of breast cancer and for evaluating the extent of cancer before surgery.

Computed Tomography (CT) : CT scans are not typically used for breast cancer diagnosis but may be used to assess the extent of disease if metastasis is suspected.

🔬 Biopsy

A biopsy is the only way to definitively diagnose breast cancer. It involves removing a sample of tissue or cells from the breast for examination under a microscope. Types of biopsies include:

Fine needle aspiration (FNA) : Uses a thin needle to remove cells from the abnormal area.
Core needle biopsy: Uses a larger needle to remove a small piece of tissue.
Vacuum-assisted core biopsy: Uses a needle attached to a suction device to remove a larger amount of tissue.
Surgical (open) biopsy: During surgery, a lump is removed.

📊 Hormone Receptor and HER2 Testing

After diagnosis, the tumor is tested for estrogen receptors (ER) , progesterone receptors (PR) , and HER2 protein. This information is critical for determining treatment options. Tumors that are ER-positive or PR-positive may respond to hormone therapy, while HER2-positive tumors may benefit from targeted therapies.

🧬 Genomic Testing

Multigene tests, such as Oncotype DX or MammaPrint, can be used to assess the risk of recurrence and guide treatment decisions for some types of breast cancer.

📊 Stages of Breast Cancer: The TNM System

Breast cancer staging describes the extent of cancer in the body. The most widely used system is the TNM system, developed by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC).

🔬 TNM Categories

T (Tumor) : Describes the size and location of the primary tumor. T categories range from T0 (no evidence of primary tumor) to T4 (tumor extends into the chest wall or skin).
N (Lymph Nodes) : Indicates whether cancer has spread to nearby lymph nodes. N categories range from N0 (no cancer in lymph nodes) to N3 (cancer in many lymph nodes).
M (Metastasis) : Indicates whether cancer has spread to distant organs. M0 means no distant metastasis; M1 means distant metastasis is present.

🎯 Stage Groups

Based on TNM, grade, and biomarker status, breast cancer is assigned a stage from 0 to IV:

Stage 0: Carcinoma in situ (DCIS or LCIS). Abnormal cells are confined to their original location and have not spread.
Stage I: Invasive cancer. The tumor is small (≤2 cm) and has not spread to lymph nodes or has only spread to a few lymph nodes.
Stage II: The tumor is larger (2–5 cm) or has spread to a few nearby lymph nodes.
Stage III: Locally advanced cancer. The tumor is larger than 5 cm or has spread to multiple lymph nodes, or has invaded the chest wall or skin.
Stage IV: Metastatic cancer. The cancer has spread to distant organs such as the bones, liver, lungs, or brain.

Staging is critical for determining prognosis and selecting the most appropriate treatment.

🌐 Metastasis: The Spread of Breast Cancer

Metastasis is the spread of cancer cells from the primary tumor to distant organs. It is responsible for the majority of cancer-related deaths. Breast cancer most commonly metastasizes to the bones, liver, lungs, and brain.

The metastatic cascade involves several steps: cancer cells break away from the primary tumor, invade surrounding tissue, enter the bloodstream or lymphatic system, travel through the body, and establish secondary tumors in distant organs.

🦴 Common Sites of Metastasis

Bone: The most common site of distant metastasis, occurring in up to 60–75% of cases. Bone metastases can cause pain, fractures, and spinal cord compression.
Lung: Lung metastases occur in up to 32–37% of cases.
Liver: Liver metastases occur in up to 32–35% of cases.
Brain: Brain metastases occur in up to 10% of cases.

The specific pattern of metastasis depends on the molecular subtype of the cancer. For example, luminal subtypes most commonly metastasize to the bone, while triple-negative breast cancer characteristically exhibits lung metastases, and HER2-enriched breast cancer commonly metastasizes to the brain, liver, and lungs.

The site of metastasis significantly affects survival. Patients with bone-only metastases have the best overall survival (41 months), while those with brain-only metastases have the worst (11 months).

📈 Cure Rate and Survival Rate

Survival rates for breast cancer have improved dramatically over recent decades due to earlier detection and more effective treatments.

🎯 5-Year Relative Survival Rates by Stage

The 5-year relative survival rate compares people with the same type and stage of cancer to people in the overall population. These numbers are based on women diagnosed with breast cancer between 2015 and 2021:

Localized disease (Stages 0–I) : The 5-year relative survival rate is >99%. The cancer is confined to the breast and has not spread.
Regional disease (Stages II–III) : The 5-year relative survival rate is 87%. The cancer has spread to nearby lymph nodes or structures.
Distant metastatic disease (Stage IV) : The 5-year relative survival rate is 32%. The cancer has spread to distant organs.
All stages combined: The overall 5-year relative survival rate is 92%.

📊 Long-Term Survival

For women diagnosed with early-stage breast cancer, long-term survival is excellent. Many women with localized breast cancer live for decades after diagnosis. Even for metastatic breast cancer, advances in treatment have extended survival, with some patients living for many years.

⏳ Life Expectancy With and Without Treatment

The natural history of untreated breast cancer varies widely depending on the stage and molecular subtype.

⏳ Without Treatment

Studies of untreated breast cancer show that in most reports, patients survive approximately 3–4 years without any type of treatment, and approximately 5–10% of untreated patients live longer than 10 years. A historical analysis of more than 1,000 untreated cases found a 5-year survival of 18.4% and a 10-year survival of 3.6%.

For untreated triple-negative breast cancer, median survival times are 65 months (stage I), 28 months (stage II), 11 months (stage III), and 3 months (stage IV).

💊 With Treatment

With modern treatment, outcomes are dramatically better. For metastatic breast cancer, median survival with surgery is 4.4 to 6.0 years, with nonsurgical treatment is 1.6 to 2.2 years, and without treatment is 0.03 to 0.13 years. The overall 5-year relative survival rate for all stages combined is now 92%.

📌 Facts and Statistics

Breast cancer is the most commonly diagnosed cancer among women worldwide.
In 2025, an estimated 316,950 new cases of invasive breast cancer and 59,080 cases of ductal carcinoma in situ (DCIS) are projected in the United States. About 42,170 women are expected to die from breast cancer.
Approximately 1 in 8 women in the United States will be diagnosed with invasive breast cancer during their lifetime, and 1 in 43 will die from the disease.
Worldwide, 1 in 20 women will be diagnosed with breast cancer in their lifetime. If current rates continue, by 2050 there will be 3.2 million new breast cancer cases and 1.1 million breast cancer-related deaths per year.
Incidence rates for invasive lobular carcinoma (ILC) have increased more steeply (2.8% per year) than all other breast cancers combined (0.8% per year) from 2012 to 2021.
The 5-year relative survival rate for localized breast cancer is >99% , for regional disease is 87% , and for distant metastatic disease is 32%.
Triple-negative breast cancer accounts for about 15–20% of all breast cancers and is more common in younger women.
Inflammatory breast cancer accounts for about 1% of all breast cancers and is highly aggressive.

❓ Questions and Answers

What is breast cancer?

Breast cancer is a malignant tumor that develops in the breast tissue, most commonly in the cells lining the milk ducts or the lobules that produce milk.

What is the ICD-10 code for breast cancer?

The ICD-10 code for malignant neoplasm of the breast is C50, with subcategories based on the specific location within the breast.

What are the most common types of breast cancer?

Invasive ductal carcinoma (IDC) is the most common type, followed by invasive lobular carcinoma (ILC). Other types include inflammatory breast cancer, triple-negative breast cancer, Paget disease, and phyllodes tumors.

Can breast cancer be prevented?

There is no sure way to prevent breast cancer, but maintaining a healthy weight, limiting alcohol, staying physically active, and eating a balanced diet may reduce risk. For high-risk women, chemoprevention or risk-reducing surgery may be options.

What are the early warning signs of breast cancer?

The most common symptom is a new lump or mass in the breast. Other signs include swelling, skin changes (dimpling, redness), nipple discharge, and nipple inversion. Many women with early-stage breast cancer have no symptoms.

How is breast cancer diagnosed?

Diagnosis involves a triple test: clinical breast examination, imaging (mammogram, ultrasound, MRI), and biopsy. A biopsy is the only way to definitively diagnose breast cancer.

What is the difference between DCIS and invasive breast cancer?

Ductal carcinoma in situ (DCIS) is a non-invasive form where abnormal cells are confined to the milk ducts. Invasive breast cancer has spread beyond the ducts into surrounding breast tissue.

What are the treatment options for breast cancer?

Treatment options include surgery (lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy, targeted therapy, and immunotherapy. The choice depends on the stage, molecular subtype, and patient factors.

What is the survival rate for breast cancer?

The 5-year relative survival rate for localized breast cancer is >99%, for regional disease is 87%, and for metastatic disease is 32%. The overall 5-year survival rate is 92%.

Where does breast cancer spread?

Breast cancer most commonly metastasizes to the bones, liver, lungs, and brain.

What is the life expectancy with metastatic breast cancer?

With treatment, median survival for metastatic breast cancer is approximately 4.4 to 6.0 years with surgery and 1.6 to 2.2 years with nonsurgical treatment. Without treatment, survival is typically 3–4 years.

What is triple-negative breast cancer?

Triple-negative breast cancer (TNBC) is a subtype that lacks estrogen receptors, progesterone receptors, and HER2 protein. It accounts for 15–20% of breast cancers and is more aggressive with a higher risk of recurrence.

Does breastfeeding reduce breast cancer risk?

Yes, studies suggest that breastfeeding may slightly reduce the risk of breast cancer, especially if continued for a year or more.

Can men get breast cancer?

Yes, men can develop breast cancer, though it is rare. Male breast cancer accounts for less than 1% of all breast cancer cases.

What is inflammatory breast cancer?

Inflammatory breast cancer is a rare and aggressive form in which cancer cells block lymph vessels in the skin of the breast, causing redness, swelling, and warmth. It accounts for about 1% of breast cancers.

How often should I get a mammogram?

The American Cancer Society recommends that women at average risk have the option to start annual mammograms at age 40, begin annual mammograms at age 45, and can switch to biennial screening at age 55.

🎯 Key Takeaways and Conclusions

Breast cancer is the most commonly diagnosed cancer among women worldwide, classified under ICD-10 code C50.
Invasive ductal carcinoma is the most common type, followed by invasive lobular carcinoma. Rarer types include inflammatory, triple-negative, and Paget disease.
Genetic factors, particularly BRCA1 and BRCA2 mutations, account for 5–10% of breast cancers. About 1 in 2 women with these mutations will develop breast cancer.
Prevention strategies include maintaining a healthy weight, limiting alcohol, staying physically active, and adhering to screening guidelines.
Early detection through mammography significantly improves survival. The ACS recommends women begin screening at age 40–45.
Diagnosis involves a triple test: clinical examination, imaging (mammogram, ultrasound, MRI), and biopsy. Hormone receptor and HER2 testing guide treatment.
Staging using the TNM system determines prognosis and treatment. Stage IV indicates metastatic disease.
Treatment is multimodal and may include surgery, radiation, chemotherapy, hormone therapy, targeted therapy, and immunotherapy. Treatment plans are personalized based on cancer subtype and stage.
Metastasis most commonly affects the bones, liver, lungs, and brain. The site of metastasis significantly impacts survival.
Survival rates are excellent for localized disease (>99% at 5 years) but drop to 32% for metastatic disease. The overall 5-year survival rate is 92%.
Life expectancy without treatment is typically 3–4 years, with only 5–10% surviving beyond 10 years. With treatment, outcomes are dramatically better.
Facts and statistics reveal a growing global burden, with 3.2 million new cases projected by 2050. Continued research, improved screening, and equitable access to treatment are essential to reducing the impact of this disease.

Breast cancer remains a significant health challenge, but with continued advances in research, early detection, and personalized treatment, the outlook for women and men diagnosed with this disease continues to improve.

📚 References

World Health Organization. Breast Cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer

National Cancer Institute. Breast Cancer Treatment (PDQ®). https://www.cancer.gov/types/breast/patient/breast-treatment-pdq

Centers for Disease Control and Prevention. Breast Cancer Statistics. https://www.cdc.gov/cancer/breast/statistics/index.htm

American Cancer Society. Breast Cancer. https://www.cancer.org/cancer/types/breast-cancer.html

MSD Manual Consumer Version. Breast Cancer. https://www.msdmanuals.com/home/cancer/breast-cancer/breast-cancer

Cancer Research UK. Types of Breast Cancer. https://www.cancerresearchuk.org/about-cancer/breast-cancer/stages-types/types

National Cancer Institute. Genetics of Breast and Gynecologic Cancers (PDQ®). https://www.cancer.gov/types/breast/hp/breast-ovarian-genetics-pdq

American Cancer Society. Breast Cancer Risk and Prevention. https://www.cancer.org/cancer/types/breast-cancer/risk-and-prevention.html

Mayo Clinic. Breast Cancer Prevention: Ways to Reduce Your Risk. https://www.mayoclinic.org/diseases-conditions/breast-cancer/in-depth/breast-cancer-prevention/art-20045641

MSD Manual Consumer Version. Breast Cancer Screening and Prevention. https://www.msdmanuals.com/home/cancer/breast-cancer/breast-cancer-screening-and-prevention

Cancer Australia. Tests for Breast Cancer. https://www.canceraustralia.gov.au/cancer-types/breast-cancer/how-breast-cancer-diagnosed/tests-breast-cancer

National Cancer Institute. Stages of Breast Cancer. https://www.cancer.gov/types/breast/stages

American Cancer Society. Survival Rates for Breast Cancer. https://www.cancer.org/cancer/types/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html

National Cancer Institute. Breast Cancer Types. https://www.cancer.gov/types/breast/breast-cancer-types

American Cancer Society. Treatment of Breast Cancer by Stage. https://www.cancer.org/cancer/types/breast-cancer/treatment/treatment-of-breast-cancer-by-stage.html

National Cancer Institute. Treatment of Breast Cancer. https://www.cancer.gov/types/breast/patient/breast-treatment-pdq

Centers for Disease Control and Prevention. Treatment of Breast Cancer. https://www.cdc.gov/cancer/breast/treatment.htm

ScienceDirect. Visceral Metastasis. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/visceral-metastasis

Nature. Patterns and prognostic implications of distant metastasis in breast cancer. https://www.nature.com/articles/s41598-025-07114-2

IARC. Breast cancer cases and deaths are projected to rise globally. https://www.iarc.who.int/news-events/breast-cancer-cases-and-deaths-are-projected-to-rise-globally/

American Cancer Society. Cancer Facts & Figures 2025. https://www.cancer.org/research/cancer-facts-statistics.html

PubMed. Survival among Patients with Untreated Metastatic Breast Cancer. https://pubmed.ncbi.nlm.nih.gov/

PubMed. Survivorship in untreated breast cancer patients. https://pubmed.ncbi.nlm.nih.gov/

National Comprehensive Cancer Network (NCCN). Breast Cancer Guidelines. https://www.nccn.org/guidelines

U.S. Preventive Services Task Force. Breast Cancer Screening. https://www.uspreventiveservicestaskforce.org/

American College of Physicians. Screening for Breast Cancer in Asymptomatic, Average-Risk Adult Females. https://www.acpjournals.org/

American College of Obstetricians and Gynecologists. Breast Cancer Screening. https://www.acog.org/

UpToDate. Patient education: Breast cancer screening (Beyond the Basics). https://www.uptodate.com/

National Cancer Institute. Breast Cancer Diagnosis. https://www.cancer.gov/types/breast/patient/breast-diagnosis-pdq

National Cancer Institute. Breast Cancer Staging. https://www.cancer.gov/types/breast/patient/breast-staging-pdq

National Cancer Institute. Breast Cancer Prevention. https://www.cancer.gov/types/breast/patient/breast-prevention-pdq

National Cancer Institute. Breast Cancer Genetics. https://www.cancer.gov/types/breast/patient/breast-genetics-pdq

World Cancer Research Fund. Diet, Nutrition, Physical Activity and Breast Cancer. https://www.wcrf.org/

American Institute for Cancer Research. Breast Cancer Risk Factors. https://www.aicr.org/

Breast Cancer Now. Breast Cancer Information. https://breastcancernow.org/

Susan G. Komen. Breast Cancer Facts. https://www.komen.org/

Breastcancer.org. Breast Cancer Information. https://www.breastcancer.org/

Zero Breast Cancer. Breast Cancer Facts. https://www.zerobreastcancer.org/

National Breast Cancer Foundation. Breast Cancer Facts. https://www.nationalbreastcancer.org/

Living Beyond Breast Cancer. Breast Cancer Information. https://www.lbbc.org/

Metastatic Breast Cancer Network. Metastatic Breast Cancer Facts. https://www.mbcn.org/

Young Survival Coalition. Young Women and Breast Cancer. https://www.youngsurvival.org/

Tigerlily Foundation. Breast Cancer Disparities. https://tigerlilyfoundation.org/

Sisters Network. African American Breast Cancer. https://sistersnetworkinc.org/

National Cancer Institute. SEER Cancer Statistics Review. https://seer.cancer.gov/

International Agency for Research on Cancer. GLOBOCAN 2022. https://gco.iarc.fr/

World Health Organization. International Classification of Diseases (ICD-10). https://icd.who.int/

American Society of Clinical Oncology. Breast Cancer. https://www.cancer.net/cancer-types/breast-cancer

European Society for Medical Oncology. Breast Cancer Guidelines. https://www.esmo.org/guidelines

National Institute for Health and Care Excellence. Breast Cancer Guidelines. https://www.nice.org.uk/guidance

Was it helpfull? Rate this article:
5 Stars4 Stars3 Stars2 Stars1 Star (11 votes, average: 4.82 out of 5)